 | vTv Therapeutics Inc
www.bloomberg.com - March 24 at 9:18 PM |
 | vTv Therapeutics (NASDAQ:VTVT) Rating Reiterated by HC Wainwright
www.americanbankingnews.com - March 18 at 9:23 AM |
 | Has vTv Therapeutics (VTVT) Outpaced Other Medical Stocks This Year?
finance.yahoo.com - March 12 at 1:42 PM |
 | 100 Stocks Moving In Thursday's Mid-Day Session
feeds.benzinga.com - February 27 at 12:54 PM |
| vTv Therapeutics Inc. (VTVT) Shares March Higher, Can It Continue?
finance.yahoo.com - February 24 at 2:07 PM |
 | vTv Therapeutics EPS misses by $0.08
seekingalpha.com - February 21 at 8:31 AM |
| vTv Therapeutics Announces 2019 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
finance.yahoo.com - February 20 at 11:51 PM |
 | VTV Therapeutics 'Close To The Finish Line' On What FDA, Diabetes Patients Want: An Adjunct Therapy To Insulin
www.msn.com - February 19 at 1:27 PM |
| vTv Therapeutics: A Promising Small Molecule Drug Discovery Pick For 2020
seekingalpha.com - February 17 at 1:19 PM |
| Catalyst Biosciences Results Positive, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - February 11 at 2:00 PM |
| vTv Therapeutics (NASDAQ: VTVT)
www.benzinga.com - February 10 at 5:42 PM |
| Mid-Afternoon Market Update: Dow Rises 70 Points; vTv Therapeutics Shares Jump
feeds.benzinga.com - February 10 at 3:33 PM |
| TSLA, INO among premarket gainers
seekingalpha.com - February 10 at 12:42 PM |
| 8 Biotechnology Stocks Moving In Monday's Pre-Market Session
www.benzinga.com - February 10 at 12:42 PM |
| VTV Therapeutics Shares Hit 16-Month High After Diabetes Drug Aces Midphase Study
www.benzinga.com - February 10 at 12:42 PM |
| Vtv Therapeutics up 67% premarket on positive TTP399 data
seekingalpha.com - February 10 at 7:41 AM |
| vTv Therapeutics Announces Positive Results from Part 2 of the Phase 2 Simplici-T1 Study of TTP399, Potential First-in-Class Oral Adjunctive Therapy for Patients with Type 1 Diabetes
finance.yahoo.com - February 10 at 7:41 AM |
| VTv Therapeutics up 21% after hours ahead of key data readout
seekingalpha.com - February 7 at 8:03 PM |
| vTv Therapeutics to Host Investor Call and Announce Results from Part 2 of the Phase 2 Simplici-T1 Study of TTP399 – Potential First-in-Class Oral Adjunctive Therapy for Patients with Type 1 Diabetes
finance.yahoo.com - February 7 at 8:03 PM |
| VTv Therapeutics +7% as Perelman boosts stake
seekingalpha.com - January 7 at 8:43 PM |
| 15 storylines to watch in the '20s: Oasis in the Triad
finance.yahoo.com - January 3 at 10:24 AM |
| High Point company to complete Phase 2 of Alzheimer’s study by 2021
www.msn.com - December 23 at 7:23 PM |
| vTv Therapeutics to complete Phase 2 of Alzheimer’s study by 2021
finance.yahoo.com - December 19 at 8:00 AM |
| Executive chairman of vTv Therapeutics resigns
finance.yahoo.com - December 2 at 8:55 AM |
| vTv Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - December 2 at 8:55 AM |
| vTv Therapeutics EPS misses by $0.07
seekingalpha.com - October 30 at 10:26 PM |
| VTv Therapeutics (VTVT) Reports Q3 Loss, Misses Revenue Estimates
finance.yahoo.com - October 30 at 10:26 PM |
 | vTv Therapeutics (Class A)
www.fool.com - October 23 at 1:48 PM |
 | VTVT.A - vTv Therapeutics Inc Profile | Reuters
www.reuters.com - October 7 at 8:18 AM |
| vTv to Host Key Opinion Leader Event to Discuss the Type 1 Diabetes Treatment Landscape and Emerging Therapies as Adjuncts to Insulin
finance.yahoo.com - October 3 at 5:20 PM |
| Vtv Therapeutics up 5% premarket on positive TTP399 data
seekingalpha.com - September 18 at 10:48 AM |
| vTv Therapeutics Presents Additional Positive Data from the Phase 2 Simplici-T1 Study in Patients with Type 1 Diabetes at 55th Annual Meeting of the European Association for the Study of Diabetes
finance.yahoo.com - September 18 at 10:48 AM |
| Biotech Stock On The Radar: vTv Therapeutics' Diabetes Pipeline
feeds.benzinga.com - September 17 at 5:12 PM |
 | vTv Therapeutics’ largest holder purchases $1 million in shares
www.bizjournals.com - September 14 at 4:31 PM |
| vTv Therapeutics to Present Posters at Two Scientific Conferences in September
finance.yahoo.com - September 11 at 2:43 PM |
 | Thursday 9/5 Insider Buying Report: YEXT, VTVT
www.nasdaq.com - September 5 at 11:13 AM |
| vTv Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment Conference
finance.yahoo.com - September 4 at 11:51 AM |
| Largest Insider Trades of the Week
finance.yahoo.com - August 30 at 11:49 PM |
| Wednesday 8/7 Insider Buying Report: VTVT, DOW
www.nasdaq.com - August 7 at 10:41 PM |
| vTv Therapeutics to Participate in Upcoming Canaccord Genuity and Solebury Trout Conferences
finance.yahoo.com - August 7 at 5:38 PM |
| vTv Therapeutics Announces 2019 Second Quarter Financial Results and Update
finance.yahoo.com - July 31 at 5:44 PM |
| VTv Therapeutics to present at Alzheimer's conference; shares +8.8%
seekingalpha.com - July 16 at 9:49 AM |
| vTv Therapeutics to Present at 2019 Alzheimer’s Association International Conference
finance.yahoo.com - July 15 at 5:38 PM |
| vTv's majority stockholder to sell 16.45M shares
seekingalpha.com - July 5 at 5:17 PM |
| Mid-stage study underway for vTv's azeliragon in Alzheimer's and T2D; shares up 8% after hours
seekingalpha.com - June 27 at 5:34 PM |
| Wednesday 6/26 Insider Buying Report: AKRO, VTVT
www.nasdaq.com - June 27 at 9:45 AM |
| VTv Therapeutics: Unreasonably Cheap
seekingalpha.com - June 7 at 5:32 PM |
| vTv Therapeutics Reports Positive Midstage Trial Results For Type 1 Diabetes Drug
www.benzinga.com - June 6 at 5:49 PM |
| vTv Therapeutics Announces Positive Topline Results from Part 1 of the Phase 2 Simplici-T1 Trial in Patients with Type 1 Diabetes
finance.yahoo.com - June 6 at 9:36 AM |
| Biotech entrepreneur seeks approval of 80-acre Triad R&D campus with 1,600 jobs
finance.yahoo.com - May 29 at 6:01 PM |
